Workforce development in community pharmacies in England: Opportunities and tensions for a private sector provider of NHS services
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Pharmacy Integration Fund (PhIF) learning pathways transformed community pharmacy workforces by developing clinical skills. Employer support and clear purpose were key to successful workforce integration in primary care.
Area Of Science
- Pharmacy Practice Research
- Health Workforce Development
- Primary Care Integration
Background
- National Health Service (NHS) England policy aims to integrate community pharmacy workforce capabilities into primary care.
- The Pharmacy Integration Fund (PhIF) was established in 2016 to advance clinical pharmacy practice in community settings.
- This study evaluates the impact of PhIF-funded learning pathways on community pharmacy workforce transformation.
Purpose Of The Study
- To investigate how PhIF-funded learning pathways facilitated community pharmacy workforce transformation.
- To understand the circumstances and underlying reasons for this transformation.
- To explore the experiences of pharmacists and pharmacy technicians undergoing these pathways.
Main Methods
- A realist evaluation approach was employed.
- Two core programme theories of the PhIF were identified and tested.
- Data were gathered through 41 semi-structured qualitative interviews with learners, supervisors, and employers.
Main Results
- Findings supported the initial programme theories, confirming the positive impact of learning pathways.
- Pharmacists developed and consolidated clinical skills, preparing them for advanced qualifications like independent prescribing.
- Employer support was crucial for learner participation, influenced by perceived value and clarity of purpose.
Conclusions
- Policymakers must consider contextual factors and stakeholder engagement mechanisms when designing workforce transformation initiatives.
- Engaging diverse private businesses in mixed-economy healthcare settings requires careful consideration of influencing factors.
- Successful integration of community pharmacy into primary care necessitates understanding and addressing stakeholder motivations and barriers.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...